Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Journal:
Current Drug Therapy
Volume:
7
Page:
281-289
Author(s):
Ravindra R. Chuda, Prakash Vishnu and David Aboulafia
Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated with Varicose Veins
Journal:
Current Drug Targets
Volume:
14
Page:
287-324
Author(s):
Arda Kucukguven and Raouf A. Khalil
T Cell Replicative Senescence in Human Aging
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
1680-1698
Author(s):
Jennifer P. Chou and Rita B. Effros
An Update of the Published Reports on Biologics Use for Psoriasis and the Reimbursement Status in Asia-Pacific Region
Journal:
Current Rheumatology Reviews
Volume:
8
Page:
227-234
Author(s):
Tsen-Fang Tsai and Ting-Yu Yeh
HtrA Protease Family as Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
977-1009
Author(s):
Joanna Skorko-Glonek, Dorota Zurawa-Janicka, Tomasz Koper, Miroslaw Jarzab, Donata Figaj, Przemyslaw Glaza and Barbara Lipinska
Plasmodium Drug Targets Outside the Genetic Control of the Parasite
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
282-289
Author(s):
David J. Sullivan
Randomized Controlled Trials in Maintenance of Remission in Crohn’s Disease
Journal:
Reviews on Recent Clinical Trials
Volume:
7
Page:
270-283
Author(s):
Renata D’Inca and Roberta Caccaro
Viral Encephalitis: Current Treatments and Future Perspectives
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
12
Page:
277-285
Author(s):
Renan Barros Domingues
Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Journal:
Current Drug Abuse Reviews
Volume:
5
Page:
243-253
Author(s):
Andres Deik, Rachel Saunders-Pullman and Marta San Luciano
L-Type Voltage-Dependent Calcium Channels As Therapeutic Targets for Neurodegenerative Diseases
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
4816-4827
Author(s):
T. Yagami, H. Kohma and Y. Yamamoto